Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Change in Account Payables (2024 - 2025)

Historic Change in Account Payables for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to -$32.7 million.

  • Abivax's Change in Account Payables fell 31808.78% to -$32.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.0 million, marking a year-over-year change of. This contributed to the annual value of -$3.7 million for FY2024, which is 11071.33% down from last year.
  • Per Abivax's latest filing, its Change in Account Payables stood at -$32.7 million for Q3 2025, which was down 31808.78% from $1.1 million recorded in Q2 2025.
  • Abivax's 5-year Change in Account Payables high stood at $15.0 million for Q3 2024, and its period low was -$32.7 million during Q3 2025.